Young Park on LinkedIn: Guardant Health to present 17 scientific abstracts highlighting…
AmirAli Talasaz on LinkedIn: Proud of Guardant Health Team and launch of GuardantREVEAL. Moving step by…
Guardant Health (@GuardantHealth) / X
Guardant Health (@GuardantHealth) / X
Guardant360 CDx submitted for regulatory approval in Japan - Guardant Health AMEA
All events - GuardantHealth
Guardant Health, Inc. - Guardant Health Announces Shield™ Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk Adults
Sampled Genomics Lab Project Guardant Health
First liquid biopsy to receive FDA Approval… - Guardant Health AMEA
press release
First liquid biopsy to receive FDA Approval for comprehensive tumor mutation profiling across all solid cancers, Guardant Health's Guardant360® CDx, advancing precision oncology in Asia, Middle East and Africa - Guardant Health
Guardant Health (GH) Q4 2018 Earnings Conference Call Transcript
Musa Tariq Joins Guardant Health Board of Directors
Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology Drug Development - Guardant Health AMEA
Guardant Health (@GuardantHealth) / X
Guardant Health | Redwood City CA
Guardant Health Initiates New Study to Examine the Impact of Shield™ Blood Test to Increase Screening Compliance for Colorecta
Press Releases - GuardantHealth
Guardant Health announces reimbursement approval of | GH Stock News
Guardant Health (@GuardantHealth) / X
CAHE Conducts New Study to Examine Patient Preference for Shield, Guardant Health's Blood Test to Screen for Colorectal Cancer – UChicago
Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers – enlightenbio Blog
Guardant Health Statement on Biden-Harris Administration's Renewed Commitment to the Cancer Moonshot - GuardantHealth
Shield by Guardant Health | Guardant Health | Blood-Based Screening
Discoveries in Health Policy: Liquid Biopsy Panel from Guardant Health Awarded "EXPEDITED PATHWAY" at FDA
EUCOPE launches new EU Coalition for Genomic Profiling
Guardant Health settles Illumina lawsuit over gene-sequencing technology | Reuters
